INTRA-CELLULAR THERAPIES INC
INTRA-CELLULAR THERAPIES INC
Action · US46116X1019 · ITCI · A1XDTL (XNAS)
Aperçu Indicateurs financiers
Pas de cours
n/a

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
- - 0,00 % 0,49 % 58,85 % 94,61 % 554,54 %

Profil de l'entreprise pour INTRA-CELLULAR THERAPIES INC Action

Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in developing lumateperone, which is in Phase III clinical trial for the treatment of bipolar depression, as well as to treat autism spectrum disorder; and in additional neuropsychiatric indications, such as sleep disorders associated with neuropsychiatric and neurological disorders. In addition, the company is developing Lenrispodun (ITI-214) for the treatment of Parkinson's disease and heart failure; ITI-1284-ODT-SL for the treatment of neuropsychiatric disorders and behavioral disturbances in dementia; and ITI-333 for substance use disorders, pain, and psychiatric comorbidities, including depression and anxiety. Intra-Cellular Therapies, Inc. was founded in 2002 and is headquartered in New York, New York.

Fonds investis

Les fonds suivants ont investi dans : INTRA-CELLULAR THERAPIES INC investi :

Fonds
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)
Vol. en millions
93,59
Part (%)
0,22 %

Données de l'entreprise

Nom INTRA-CELLULAR THERAPIES INC
Société Intra-Cellular Therapies, Inc.
Symbole ITCI
Site web https://www.intracellulartherapies.com
Marché d'origine XNAS NASDAQ
WKN A1XDTL
ISIN US46116X1019
Type de titre Action
Secteur Healthcare
Industrie Drug Manufacturers - Specialty & Generic
PDG Dr. Sharon Mates Ph.D.
Capitalisation boursière 14 Mrd.
Pays États-Unis d'Amérique
Devise USD
Employés 0,9 T
Adresse 430 East 29th Street, 10016 New York
Date d'introduction en bourse 2014-01-07

Symboles boursiers

Nom Symbole
Frankfurt 23I.F
NASDAQ ITCI

Autres actions

Les investisseurs qui détiennent INTRA-CELLULAR THERAPIES INC ont également les actions suivantes dans leur portefeuille :
88 ENERGY LTD
88 ENERGY LTD Action
ALLY FINANCIAL INC
ALLY FINANCIAL INC Action
ALPHABET INC - CLASS A
ALPHABET INC - CLASS A Action
AMAZON.CO INC
AMAZON.CO INC Action
AMGEN INC
AMGEN INC Action
APPLE INC
APPLE INC Action
AUTODESK INC
AUTODESK INC Action
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Action
INTEL CORP
INTEL CORP Action
MD MEDICAL GROUP INVESTMENTS PLC - GDR (EACH REPR 1 ORD) (144A)
MD MEDICAL GROUP INVESTMENTS PLC - GDR (EACH REPR 1 ORD) (144A) Certificat de dépôt
MICROSOFT CORP
MICROSOFT CORP Action
NVIDIA CORP
NVIDIA CORP Action
SHELL PLC        WI ADR/2
SHELL PLC WI ADR/2 Action
WALGREENS BOOTS ALLIANCE INC
WALGREENS BOOTS ALLIANCE INC Action
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025